Objective:

To evaluate the efficacy and safety of tranexamic acid (TXA) in reducing hemorrhagic complications during bariatric surgery, particularly in the context of sleeve gastrectomy and Roux-en-Y gastric bypass.

Key Findings:

• TXA administration was associated with a significant reduction in postoperative bleeding, quantified as a decrease of X mL (insert specific data if available).
• No increase in thrombotic events or mortality was observed with TXA use.
• Length of stay and operative time showed no significant differences between TXA and control groups.

Interpretation:

The findings support the use of TXA as a safe adjunct to reduce bleeding complications in bariatric surgery, enhancing patient outcomes and potentially influencing clinical protocols.

Limitations:

• Limited by the small sample sizes of included studies, which may affect the generalizability of the results.
• Variability in definitions and measurements of intraoperative bleeding across studies may introduce bias.

Conclusion:

Tranexamic acid appears to be an effective and safe option for reducing hemorrhagic complications in bariatric surgery, warranting further research to explore its broader application and optimal dosing strategies.